Automate Your Wheel Strategy on CVS
With Tiblio's Option Bot, you can configure your own wheel strategy including CVS - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol CVS
- Rev/Share 310.5469
- Book/Share 57.6123
- PB 1.3524
- Debt/Equity 1.121
- CurrentRatio 0.8319
- ROIC 0.0043
- MktCap 98660292734.0
- FreeCF/Share 4.959
- PFCF 15.6778
- PE 210.2914
- Debt/Assets 0.3202
- DivYield 0.0342
- ROE 0.0062
- Rating B+
- Score 3
- Recommendation Neutral
- P/E Score 1
- DCF Score 5
- P/B Score 4
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Initiation | CVS | Goldman | -- | Buy | -- | $91 | Oct. 14, 2025 |
| Upgrade | CVS | UBS | Neutral | Buy | -- | $79 | Aug. 18, 2025 |
| Upgrade | CVS | Robert W. Baird | Neutral | Outperform | -- | $82 | Aug. 14, 2025 |
| Upgrade | CVS | Leerink Partners | Market Perform | Outperform | $55 | $75 | Feb. 13, 2025 |
| Upgrade | CVS | Cantor Fitzgerald | Neutral | Overweight | -- | -- | Feb. 12, 2025 |
| Upgrade | CVS | Edward Jones | Hold | Buy | -- | -- | Jan. 30, 2025 |
| Upgrade | CVS | Deutsche Bank | Hold | Buy | -- | $66 | Dec. 3, 2024 |
| Upgrade | CVS | Barclays | Equal Weight | Overweight | $63 | $82 | Oct. 10, 2024 |
| Upgrade | CVS | TD Cowen | Hold | Buy | $59 | $85 | Oct. 4, 2024 |
News
Health Insurers Now Get a Pulse: 3 Stocks to Jump in 2026
Published: December 17, 2025 by: Zacks Investment Research
Sentiment: Neutral
Health insurers are regaining pricing control and margin visibility, putting UnitedHealth, CVS Health and Centene back in focus as managed care regains its pulse.
Read More
Is Trending Stock CVS Health Corporation (CVS) a Buy Now?
Published: December 17, 2025 by: Zacks Investment Research
Sentiment: Positive
Zacks.com users have recently been watching CVS Health (CVS) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Read More
Codoxo's Oversubscribed Series C Led by CVS Health Ventures to Revolutionize Payment Integrity for America's Largest Health Plans
Published: December 17, 2025 by: Business Wire
Sentiment: Neutral
DULUTH, Ga.--(BUSINESS WIRE)--Codoxo, the leading provider of AI and generative AI-powered healthcare payment integrity solutions, raised $35M in Series C funding, led by CVS Health Ventures. Echo Health Ventures joins the round as a new investor, with continued investment from existing investors including Sands Capital, 111 West Capital, Brewer Lane Ventures, Wipro Ventures, 450 Ventures (venture arm of Blue Cross and Blue Shield of Alabama) and QED Investors. This milestone brings Codoxo's to.
Read More
CVS Stock Gains From Offering MMR Vaccine to South Carolina Residents
Published: December 15, 2025 by: Zacks Investment Research
Sentiment: Positive
CVS Health shares jump after the company begins offering MMR vaccines across South Carolina pharmacies and clinics post a measles outbreak.
Read More
Why CVS Health (CVS) is a Top Momentum Stock for the Long-Term
Published: December 12, 2025 by: Zacks Investment Research
Sentiment: Positive
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Read More
CVS Health offering measles vaccine to South Carolina residents amid the state's current outbreak
Published: December 11, 2025 by: PRNewsWire
Sentiment: Neutral
Unvaccinated residents can receive a measles vaccine at select CVS Pharmacy and MinuteClinic locations across the state WOONSOCKET, R.I. , Dec. 11, 2025 /PRNewswire/ -- As South Carolina public health officials work to stop the spread of measles following the current outbreak in the state, CVS Health® (NYSE:CVS) is offering the measles-mumps-rubella (MMR) vaccine to residents.
Read More
CVS Health Corporation (CVS) Analyst/Investor Day Prepared Remarks Transcript
Published: December 10, 2025 by: Seeking Alpha
Sentiment: Neutral
CVS Health Corporation (CVS) Analyst/Investor Day Prepared Remarks Transcript
Read More
Buy Or Fear CVS Stock At $78?
Published: December 10, 2025 by: Forbes
Sentiment: Neutral
CVS Health's (NYSE: CVS) latest results affirm several points: their sales and adjusted profits remain stable, and they are adjusting their forecasts upward. Nonetheless, the quality of their profits and elevated debt still render the stock a “cheap but risky” option, rather than a definitive bargain.
Read More
CVS Health: Investor Day Targets Set Attractive Baseline For 2026
Published: December 09, 2025 by: Seeking Alpha
Sentiment: Positive
CVS Health is positioned for continued outperformance, with a strong turnaround driving industry-leading results and a reiterated "Buy" rating. CVS's Q3 showed 7.8% revenue growth, 47% adjusted EPS growth, and significant margin improvement, reversing prior underperformance versus peers. Investor Day guidance signals robust EPS growth through 2028, led by Healthcare Benefits and a focus on profitability over aggressive expansion.
Read More
CVS Investor Day Highlights Major Growth Ahead - Bullish Chart Into 2026
Published: December 09, 2025 by: Seeking Alpha
Sentiment: Positive
CVS Health Corporation is a top S&P 500 performer in 2025, up 78% YTD, with strong operational and financial momentum. I reiterate a Buy rating for CVS, raising my intrinsic value target to $93, based on 2026 EPS guidance and a 13x multiple. Management projects mid-teen EPS growth, robust cash flow, and improved margins across all business segments through 2028.
Read More
CVS Health updated its 2025 guidance again, and the stock is rallying
Published: December 09, 2025 by: Market Watch
Sentiment: Positive
CVS Health's stock was up about 4% at the market open on Tuesday after the company boosted its revenue and profit guidance for the year and detailed its full-year expectations for 2026.
Read More
CVS Health lifts full-year guidance during investor event
Published: December 09, 2025 by: Proactive Investors
Sentiment: Positive
CVS Health Corp (NYSE:CVS) shares moved higher on Tuesday after raising its full-year 2025 financial guidance during its Investor Day event, reflecting stronger performance across its health care businesses. The company now expects 2025 revenue of at least $400 billion, up from a prior forecast of $397.3 billion.
Read More
CVS Health generates over $474 Billion in 2024 U.S. economic impact, supporting communities throughout the United States
Published: December 05, 2025 by: PRNewsWire
Sentiment: Neutral
New report highlights the company's role as a top U.S. employer, investing in improving health and supporting local communities WOONSOCKET, R.I. , Dec. 5, 2025 /PRNewswire/ -- CVS Health® (NYSE: CVS) today released its inaugural National Economic Impact Report demonstrating the positive economic impact that the company has in communities across the country.
Read More
CVS Health Corporation (CVS) is Attracting Investor Attention: Here is What You Should Know
Published: December 03, 2025 by: Zacks Investment Research
Sentiment: Positive
Zacks.com users have recently been watching CVS Health (CVS) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Read More
Why Is CVS Health (CVS) Up 4.1% Since Last Earnings Report?
Published: November 28, 2025 by: Zacks Investment Research
Sentiment: Positive
CVS Health (CVS) reported earnings 30 days ago. What's next for the stock?
Read More
Battle of Benefits: Will UNH Deliver the Bigger Dose or CVS? (Revised)
Published: November 26, 2025 by: Zacks Investment Research
Sentiment: Positive
CVS's rising margins, stronger guidance and sharper valuation edge make it stand out in the UNH vs. CVS upside debate.
Read More
Battle of Benefits: Will UNH Deliver the Bigger Dose or CVH?
Published: November 26, 2025 by: Zacks Investment Research
Sentiment: Positive
CVS's rising margins, stronger guidance and sharper valuation edge make it stand out in the UNH vs. CVS upside debate.
Read More
CVS vs. WMT: Which Retail Pharmacy Powerhouse Looks Stronger Now?
Published: November 25, 2025 by: Zacks Investment Research
Sentiment: Positive
CVS gains momentum with record revenues, stronger guidance and a cheaper valuation, standing out in the retail pharmacy comparison with WMT.
Read More
Curaechoice Selects CVS Caremark at its PBM
Published: November 24, 2025 by: GlobeNewsWire
Sentiment: Neutral
All Active Curaechoice Members and their Families Will Have Access to CVS Pharmacies Nationwide Starting January 1 All Active Curaechoice Members and their Families Will Have Access to CVS Pharmacies Nationwide Starting January 1
Read More
CVS Aetna's New Generative AI Assistant Aims to Simplify Health Care
Published: November 20, 2025 by: Zacks Investment Research
Sentiment: Positive
CVS Health's Aetna debuts an embedded generative AI assistant designed to simplify benefits navigation and elevate the consumer health experience.
Read More
Here's Why CVS Health (CVS) is a Strong Value Stock
Published: November 20, 2025 by: Zacks Investment Research
Sentiment: Positive
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Read More
CVS Health Corporation (CVS) Is a Trending Stock: Facts to Know Before Betting on It
Published: November 19, 2025 by: Zacks Investment Research
Sentiment: Positive
CVS Health (CVS) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Read More
Aetna Launches Leading Edge Conversational AI Navigation
Published: November 18, 2025 by: PRNewsWire
Sentiment: Neutral
Embedded assistant revolutionizes how members navigate their health care journey WOONSOCKET, R.I. , Nov. 18, 2025 /PRNewswire/ -- Aetna, a CVS Health® company (NYSE: CVS), is launching a market-leading generative AI-powered conversational experience in its digital channels that will simplify health care, allowing members to quickly and easily navigate their benefits for a personalized experience.
Read More
CVS edges higher as vet group flags steady growth and Australian deal-making
Published: November 18, 2025 by: Proactive Investors
Sentiment: Positive
Shares in CVS Group (AIM:CVSG) nudged less than 1% higher after the veterinary services company said trading was in line with expectations, with early-year momentum holding up despite a tougher backdrop in the UK. At its annual meeting, the group reported sales up 5.7% in the four months to the end of October and a 6.2% rise in adjusted earnings.
Read More
Trividia Health, Inc. Announces Preferred Listing of the TRUE METRIX® Blood Glucose Systems on CVS Caremark Commercial Template Formularies
Published: November 06, 2025 by: Business Wire
Sentiment: Neutral
FT. LAUDERDALE, Fla.--(BUSINESS WIRE)-- #TRUEMETRIX--Trividia Health, Inc., announced today that it's TRUE METRIX® Self-Monitoring Blood Glucose Systems are now preferred for commercial patients on CVS Caremark Commercial Template Formularies in the United States, replacing OneTouch® branded blood glucose monitors and test strips. The TRUE METRIX® portfolio delivers scientifically backed performance built on decades of research and technological innovation. The TRUE METRIX meters and test strips feature TRIP.
Read More
Investors Heavily Search CVS Health Corporation (CVS): Here is What You Need to Know
Published: November 05, 2025 by: Zacks Investment Research
Sentiment: Positive
CVS Health (CVS) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Read More
CVS Health Boosts CVS Pharmacy Customer Generosity to Address Food Insecurity
Published: October 31, 2025 by: PRNewsWire
Sentiment: Neutral
WOONSOCKET, R.I. , Oct. 31, 2025 /PRNewswire/ -- CVS Pharmacy® customers donated more than $3 million this year to support local food banks across the country, and CVS Health® (NYSE: CVS) is boosting the overall contribution to support Feeding America.
Read More
My Top 10 High-Yield Picks For November 2025: One Yields 9%+
Published: October 30, 2025 by: Seeking Alpha
Sentiment: Positive
I present a diversified selection of high-yield dividend stocks with strong income and growth potential, including CVX, VZ, MO, ARCC, and others. Each company was selected for sustainable dividends, attractive yields, reasonable payout ratios, and a proven record or potential for dividend growth. CVX and ARCC receive positive Wall Street ratings, while VZ and MO offer high yields and strong free cash flow, supporting portfolio income stability.
Read More
CVS Posts Loss on Write-Down, Boosts Guidance
Published: October 29, 2025 by: WSJ
Sentiment: Neutral
CVS Health raised its guidance for the rest of the year, boosted by improved performance at its Aetna insurance unit.
Read More
CVS Health (CVS) Surpasses Q3 Earnings and Revenue Estimates
Published: October 29, 2025 by: Zacks Investment Research
Sentiment: Positive
CVS Health (CVS) came out with quarterly earnings of $1.6 per share, beating the Zacks Consensus Estimate of $1.36 per share. This compares to earnings of $1.09 per share a year ago.
Read More
About CVS Health Corporation (CVS)
- IPO Date 1996-11-20
- Website https://www.cvshealth.com
- Industry Medical - Healthcare Plans
- CEO J. David Joyner
- Employees 219000